Global Panic Attack Treatment Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Panic Attack Treatment Market

The panic attack treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 6.90% in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of the panic attack treatment market.  

Panic attacks are characterized by the sudden wave of fear in the people. When people suffer from panic attacks, they feel as they are unable to breathe and are having heart attacks. These panic attacks mainly occur one or two times but sometimes it may be for a longer period of time. Panic attacks can also lead to other disorders such as phobia, anxiety, depression and many others. Symptoms for the panic attacks are shortness of breath, chest pain, fear of dying, nausea, sweating and many more symptoms. There is no cure for the panic attacks and the medications and therapies work on 80% of patient’s population and 20% still suffer from the symptoms and have to live with these attacks.

The rise in prevalence of lifetime panic disorder and patients with panic disorder having life time problems of anxiety, depression, cardiovascular, respiratory, gastrointestinal and other problems such as obsessive compulsion disorder, COPD, asthma and social phobia may drive the panic attack treatment market growth. For instance, according to Anxiety and Depression Association of America, there are 6 million adults in the U.S. suffering from panic disorders in 2020. In addition, increase in patient awareness level, advancements in the treatment options and adoption of sedentary life-style are some of the impacting factors increasing the demand of panic attack treatment market. High cost of treatment and side-effects related to the drugs such as insomnia, decreased in sexual desires, tremors, dry mouth, constipation, high blood pressure, liver problems and many others are some of the factors hindering the panic attack treatment market growth.   

Increasing healthcare expenditure and support from the government are the opportunities for the panic attack treatment market growth. Challenging factor for the panic attack treatment market growth is the risk factors that are some of the patient population are at high risk if they take the medications for the panic attacks such as older population, pregnant women, bipolar disease patient and young population. So, it is very difficult for the physicians to provide them with a treatment of panic attacks.

This panic attack treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the panic attack treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Panic Attack Treatment Market Scope and Market Size

The panic attack treatment market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

• On the basis of type, the panic attack treatment market is segmented into spontaneous or uncured panic attacks, situationally bound or cured panic attack and situationally predisposed panic attacks
• On the basis of treatment, the panic attack treatment market is segmented into therapy and medications. Therapy is further segmented to cognitive behavioral therapy, exposure therapy for panic disorder and exposure therapy for panic disorder with agoraphobia. Medication is further segmented to anti-depressants and anti-anxiety drugs. Anti-depressants are further sub-segmented to selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). Selective serotonin reuptake inhibitors (SSRIs) are further sub-segmented to fluoxetine (prozac), paroxetine (paxil, pexeva) and sertraline (zoloft). Serotonin and norepinephrine reuptake inhibitors (SNRIs) are further sub-segmented to venlafaxine (Effexor XR). Anti-anxiety drugs are further segmented to benzodiazepines. Benzodiazepines are further segmented to alprazolam (Xanax) and clonazepam (klonopin).
• On the basis of route of administration, the panic attack treatment market is segmented into oral, parenteral and others.
• On the basis of end-users, the panic attack treatment market is segmented to hospitals, homecare, specialty Clinics and others.
• On the basis of distribution channel, the panic attack treatment market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.

Global Panic Attack Treatment Market Country Level Analysis

Global panic attack treatment market is analysed and market size information is provided by country, type, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the panic attack treatment market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share because of increasing prevalence of neurological disorders such as panic attacks, increase in number of FDA approval drugs and high awareness about the anxiety and depression. Asia-Pacific holds the second largest share due to change in lifestyle which led to the stress and depression resulted in panic disorders.  

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The panic attack treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to panic attack treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the panic attack treatment market in the growth period.

Competitive Landscape and Panic Attack Treatment Market Share Analysis

The panic attack treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global panic attack treatment market.

The major players covered in the global panic attack treatment market report are Teva Pharmaceutical Inc., Sun Pharmaceutical Industries Ltd, Mylan N.V., AstraZeneca, Abbott Laboratories, Actavis Pharmaceutical Company, Baxter International, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Noven Pharmaceuticals, Inc., Pfizer, Inc., Recordati Rare Diseases, Shionogi and Company, Sumitomo Dainippon Pharma, Torrent Pharmaceuticals Ltd, Sanofi among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-60569